Clinical Trial Update: Prevalence of Hepatitis B Infection in the Galilee Region, Israel

View source ↗

Summary

A clinical trial evaluating the prevalence of Hepatitis B infection in the Galilee region of Israel (NCT01645007) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Western Galilee Hospital-Nahariya | Conditions: Hepatitis B | Status: WITHDRAWN